Tuesday, November 14, 2006

Reports of Bowel Obstruction and Gastrointestinal Perforation with RITUXAN® (rituximab)

Hoffmann-La Roche Limited, in consultation with Health Canada, has informed Canadian health care professionals of important safety information concerning RITUXAN® (rituximab).

From Health Canada:
Hoffmann-La Roche Limited, in consultation with Health Canada, has informed Canadian health care professionals of important safety information concerning RITUXAN® (rituximab).
For Health Professionals...
For the Public...

No comments: